References
- Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 1992; 339(8784): 1–15; 1992; 339(8785): 71–85
- Rosen PP, et al. Prognosis INT2 N0 M0 stage 1 breast cancer: a 20-year follow-up study. J Clin Oncol 1995; 9: 1650–61